3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
13
Lung Neoplasms
7
Stomach Neoplasms
3
Adenocarcinoma Of Esophagus
3
Squamous Cell Carcinoma of Head and Neck
2
Neoplasm Metastasis
2
Esophageal Neoplasms
2
Adenocarcinoma
2
Sarcoma
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasms
1
Metastatic Gastric Adenocarcinoma
1
Head and Neck Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Advanced Gastric or EGJ Cancer
1
Interventions
Gemcitabine
15
Cisplatin
13
durvalumab
10
pembrolizumab
9
Oxaliplatin
8
Magnetic Resonance Spectroscopy
8
Specimen Handling
6
Leucovorin
6
Biopsy
6
Fluorouracil
5
Paclitaxel
4
Folfox protocol
4
Taxes
3
Radiation
3
Nivolumab
3
Irinotecan
3
Immunoglobulin G
3
Disulfides
3
tislelizumab
2
pemigatinib
2
olaparib
2
futibatinib
2
fludarabine
2
dehydroftorafur
2
Platinum
2
Liver Transplantation
2
Fluorodeoxyglucose F18
2
Floxuridine
2
Dexamethasone
2
Carboplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cholangiocarcinoma
×
Ramucirumab
×
90 days
×
Clear all
No trials found.